Natasha Hernday - May 15, 2024 Form 4 Insider Report for XOMA Corp (XOMA)

Role: Director
Signature: /s/ Thomas Burns, Attorney-in-Fact for Natasha Hernday
Stock symbol: XOMA
Transactions as of: May 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 5/17/2024, 04:30 PM
Previous filing: Jan 4, 2024
Next filing: May 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XOMA	Common Stock	Award	$0	+3.04K		$0.00	3.04K	May 15, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XOMA	Non-Qualified Share Option (right to buy)	Award	$0	+4.88K		$0.00	4.88K	May 15, 2024	Common Stock	4.88K	$24.71	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 3,035 restricted stock units ("RSUs"). Each RSU represents the right to receive, at settlement, one share of common stock of the Company and will vest on the first anniversary of the grant date, subject to the reporting person's continued service to the Company through such vesting date.
F2	The shares subject to this option shall vest and become exercisable in equal monthly installments over the 12-month period following the date of grant (May 15, 2024), provided that the final installment will occur on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the reporting person's continued service to the Company through each vesting date.

Content

Consists of 3,035 restricted stock units ("RSUs"). Each RSU represents the right to receive, at settlement, one share of common stock of the Company and will vest on the first anniversary of the grant date, subject to the reporting person's continued service to the Company through such vesting date.

The shares subject to this option shall vest and become exercisable in equal monthly installments over the 12-month period following the date of grant (May 15, 2024), provided that the final installment will occur on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the reporting person's continued service to the Company through each vesting date.